Surveillance of HIV type 1 drug resistance among naive patients from Venezuela

AIDS Research and Human Retroviruses

Volumn 25, Issue 12, 2009, Pages 1329-1333

  Castillo, Julio ^a   Comegna, Mario ^a   Quijada, Wilmary ^a   Jauvin, Valérie ^b   Pinson, Patricia ^b   Masquelier, Bernard ^b   Fleury, Hervé ^b   Castro, Erika ^c  

^a UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; ANTIVIRAL RESISTANCE; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; GENE SEQUENCE; GENETIC RECOMBINATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MAJOR CLINICAL STUDY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE ALIGNMENT; UNINDEXED SEQUENCE; VIRUS GENE; VIRUS ISOLATION; VIRUS MUTATION; VIRUS STRAIN;

ADOLESCENT; ADULT; CD4 LYMPHOCYTE COUNT; DRUG RESISTANCE, VIRAL; FEMALE; GENETIC VARIATION; GENOTYPE; HIV INFECTIONS; HIV PROTEASE; HIV REVERSE TRANSCRIPTASE; HIV-1; HUMANS; MALE; MIDDLE AGED; MUTATION; PREVALENCE; RECOMBINATION, GENETIC; VENEZUELA; YOUNG ADULT;

EID: 73149108251     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2009.0118     Document Type: Article

References (13)

1. Hirsch MS, Brun-Vézinet F, Clotet B, et al.: Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel. Clin Infect Dis 2003;37(1):113-128.
2. Shafer R and Shapiro JM: HIV-1 drug resistance mutations: An updated framework for the second decade of HAART. AIDS Rev 2008;10:67-84.
3. Delgado E, León-Ponte M, Villahermosa M, et al.: Analysis of HIV type 1 protease and reverse transcriptase sequences from Venezuela for drug resistance-associated mutations and subtype classification: A UNAIDS Study. AIDS Res Hum Retroviruses 2001;17(8):753-758.
4. Castro E, Echeverría G, Deibis L, et al.: Molecular epidemiology of HIV-1 in Venezuela: High prevalence of HIV-1 subtype B and identification of a B=F recombinant infection. J Acquir Immune Defic Syndr 2003;32(3):338-344.
5. Castro E, Moreno M, Deibis L, Salmen S, Berrueta L, and De Pérez G: Trends of HIV-1 molecular epidemiology in Venezuela: Introduction of subtype C and identification of a novel B=C mosaic genome. J Clin Virol 2005;32(3):257-258.
6. Dieudonne M, Garzaro D, Torres J, et al.: High prevalence of secondary resistance mutations in Venezuelan HIV-1 isolates. Invest Clin 2006;47(1):27-34.
7. Bouchard M, Masquelier B, Moreno M, Deibis L, De Pérez GE, Fleury H, and Castro E: HIV type 1 drug resistance among naive patients from Venezuela. AIDS Res Hum Retroviruses 2007;23(3):482-485.
8. World Health Organization=Joint United Nations Programme on HIV=AIDS: Epidemiological fact sheets on HIV=AIDS and sexually transmitted infections, Venezuela, 2006. http:== www.who.int=hiv=pub=epidemiology=pubfacts=en=.
9. Bennett DE, Bertagnolio S, Sutherland D, and Gilks CF: The World Health Organization's global strategy for prevention and assessment of HIV drug resistance. Antivir Ther 2008;13(Suppl 2):1-13.
10. Deshpande A, Jauvin V, Magnin N, Pinson P, Faure M, Masquelier B, Aurillac-Lavignolle V, and Fleury HJ: Resistance mutations in subtype C HIV type 1 isolates from Indian patients of Mumbai receiving NRTIs plus NNRTIs and experiencing a treatment failure. AIDS Res Hum Retroviruses 2007;23(2):335-340.
11. Fleury H, Recordon-Pinson P, Caumont, A, et al.: HIV type 1 diversity in France, 1999-2001: Molecular characterization of non-B HIV type 1 subtypes and potential impact on susceptibility to antiretroviral drugs. AIDS Res Hum Retroviruses 2003;19(1):41-47.
12. Chew ChB, Potter SJ, Wang B, et al.: Assessment of drug resistance mutations in plasma and peripheral blood mononuclear cells at different plasma viral loads in patients receiving HAART. J Clin Virol 2005;33(3):206-216.
13. Devereux, H, Loveday C, Youle, M, et al.: Substantial correlation between HIV type 1 drug-associated resistance mutations in plasma and peripheral blood mononuclear cells in treatment-experienced patients. AIDS Res Hum Retroviruses 2000;16(11):1025-1030.